CDC Issues Operational Planning Information to Prepare for Pediatric COVID-19 Vaccination
The Centers for Disease Control and Prevention (CDC) has issued operational planning information to prepare jurisdictions for the eventual distribution and administration of COVID-19 vaccines to the pediatric population.
Hear about Medi-Cal Rx Transition During CHA Webinar
CHA will host a webinar on Oct. 14 from 2:30 to 3:30 p.m. (PT) to update members on the transition to Medi-Cal Rx.
FDA Revises Draft Guidance on Hospital and Health System Drug Compounding
The Food and Drug Administration (FDA) has issued revised draft guidance on hospital and health system compounding under section 503A, updating draft guidance released in 2016. As advocated for by CHA, the FDA has revised the 2016 guidance to remove a requirement that would have limited the distribution of compounded drugs to health care facilities located within a one-mile radius of the compounding pharmacy.
CMS to Pay for COVID-19 Booster Shots
The Centers for Medicare & Medicaid Services has announced will pay the full cost of the Pfizer-BioNTech COVID-19 booster shots to providers without cost-sharing for Medicare, Medicaid, and the Children’s Health Insurance Program beneficiaries.
Changes Coming to Controlled Substance Utilization Review and Evaluation System in April 2022
The Department of Justice will implement two important changes to the Controlled Substance Utilization Review and Evaluation System (CURES), effective April 2022.
FDA Authorizes Pfizer COVID-19 Vaccine Boosters for Certain Individuals
The Food and Drug Administration (FDA) has amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine to allow for a booster dose for certain individuals, including health care workers.
FDA Announces Approval of Pfizer-BioNTech COVID-19 Vaccine
The Food and Drug Administration (FDA) today announced its full approval for the Pfizer-BioNTech COVID-19 vaccine — under the name Comirnaty — for individuals 16 and older, making it the first COVID-19 vaccine to go beyond emergency use authorization (EUA) in the U.S.
CDC Announces COVID-19 Vaccine Boosters for All, CMS Updates Coding Guidance
The Centers for Disease Control and Prevention (CDC) announced plans to begin offering COVID-19 booster shots to all individuals beginning the week of Sept. 20 and starting eight months after an individual’s second dose, pending authorization from the Food and Drug Administration (FDA) and a review by the CDC’s vaccine advisory committee.
CMS Formally Rescinds Most Favored Nation Part B Drug Model
The Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would formally rescind its November 2020 Most Favored Nation model interim final rule (IFR).
DHCS Announces Medi-Cal Rx Will Go Live on Jan. 1, 2022
On July 28, the Department of Health Care Services (DHCS) shared with CHA that Medi-Cal Rx will go live on Jan. 1, 2022.